| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50458-028-02 | 50458-028 | HUMAN PRESCRIPTION DRUG | Spravato | Esketamine Hydrochloride | SOLUTION | NASAL | 20190305 | N/A | NDA | NDA211243 | Janssen Pharmaceuticals Inc. | ESKETAMINE HYDROCHLORIDE | 28 mg/.2mL | 2 BLISTER PACK in 1 KIT (50458-028-02) / 1 VIAL, SINGLE-USE in 1 BLISTER PACK / .2 mL in 1 VIAL, SINGLE-USE (50458-028-00) |
| 50458-028-03 | 50458-028 | HUMAN PRESCRIPTION DRUG | Spravato | Esketamine Hydrochloride | SOLUTION | NASAL | 20190305 | N/A | NDA | NDA211243 | Janssen Pharmaceuticals Inc. | ESKETAMINE HYDROCHLORIDE | 28 mg/.2mL | 3 BLISTER PACK in 1 KIT (50458-028-03) / 1 VIAL, SINGLE-USE in 1 BLISTER PACK / .2 mL in 1 VIAL, SINGLE-USE (50458-028-00) |